Klotho Net Receivables from 2010 to 2026
| KLTOW Stock | 0.08 0 1.48% |
Net Receivables | First Reported 2010-12-31 | Previous Quarter 225 K | Current Value 200 K | Quarterly Volatility 13.2 K |
Check Klotho Neurosciences financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Klotho Neurosciences' main balance sheet or income statement drivers, such as Interest Expense of 430.6 K, Selling General Administrative of 6.7 M or Total Revenue of 0.0, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 8.6. Klotho financial statements analysis is a perfect complement when working with Klotho Neurosciences Valuation or Volatility modules.
Klotho | Net Receivables | Build AI portfolio with Klotho Stock |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Klotho Stock Analysis
When running Klotho Neurosciences' price analysis, check to measure Klotho Neurosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Klotho Neurosciences is operating at the current time. Most of Klotho Neurosciences' value examination focuses on studying past and present price action to predict the probability of Klotho Neurosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Klotho Neurosciences' price. Additionally, you may evaluate how the addition of Klotho Neurosciences to your portfolios can decrease your overall portfolio volatility.